Regeneron Pharmaceuticals
Regeneron's Cell Culture Development Group is seeking a Process Development Engineer II to develop and optimize monoclonal antibody production processes at bench scale. The role involves conducting cell culture studies, data analysis, and supporting technology transfer for clinical and commercial manufacturing.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Sr. Engineer or Sr. Scientist, API Development
Neurocrine Biosciences
Senior Research Associate, Process Development
UPSIDE Foods
Process Engineer, Cell Therapy Process Development
AstraZeneca
Principal Scientist
sanofi us
Principal Engineer, or Principal Scientist
Bora Pharmaceuticals
Associate Principal Scientist – Upstream Process Development (Temporary Maternity Cover)
AstraZeneca